A complete application in a minute
Tailored resume and cover letter, ready to send.
Novant Health's Advanced Practice Provider (NP/PA) in hematologic malignancies delivers comprehensive clinical care in a high-volume outpatient setting, collaborating with hematology physicians and the multidisciplinary care team. The APP manages scheduled and urgent patient needs along the continuum of care, including visits, treatment clearance and monitoring.
The role supports patients with leukemia, lymphoma and related disorders, including CAR-T therapy and stem cell transplant processes,
The Advanced Practice Provider (NP/PA) will provide comprehensive clinical care to patients with complex hematologic malignancies in a high-volume outpatient setting, working collaboratively with hematology physicians and the multidisciplinary care team. The APP will manage scheduled and urgent patient needs throughout the continuum of care, including new and established patient visits, treatment clearance and monitoring, symptom and toxicity management, review and interpretation of laboratory and diagnostic findings, medication management, and supportive care.
The APP will care for patients with diagnoses such as leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, and other hematologic malignancies. The APP will also play an integral role in the care of patients undergoing CAR-T cell therapy, bispecific antibody therapy, autologous stem cell transplantation, and allogeneic stem cell transplantation, including:
The APP will work closely with physicians, nursing, pharmacy, infusion, transplant and cellular therapy coordinators, navigation, and other multidisciplinary partners to coordinate complex care, provide patient and caregiver education, and ensure continuity across the patient's treatment journey. The position will also support rapid evaluation of acute concerns and early identification of complications that may require escalation to a higher level of care.
This position plays an important role in improving patient access, expanding provider capacity, supporting continuity between the inpatient and outpatient settings, and delivering safe, timely, high-quality care to an exceptionally complex and medically vulnerable malignant hematology, transplant, and cellular therapy patient population.
199918